Skip to main content

AI-Assisted ANVISA Submission Preparation

Last reviewed:

Use structured extraction and expert review to prepare an ANVISA dossier from controlled source documentation, with missing evidence tracked explicitly.

Regulatory Overview

AI-assisted ANVISA dossier preparation

Pure Global uses structured extraction, document mapping and professional review to support ANVISA submission preparation. Automation can reduce repetitive assembly work, but its value depends on the source file's quality, language, device scope and remaining evidence gaps. It does not shorten an official review clock by itself or guarantee acceptance.

Start with Brazil classification and the applicable Notification or Registration route. A foreign FDA or CE dossier can provide useful evidence, but the Brazilian requirements and current approved configuration must be assessed independently.

From source documents to a controlled filing

StageAutomation can supportExpert review must resolve
Document inventoryExtract identifiers, revisions and product referencesWhich records are authoritative, current and within scope
Requirement mappingOrganize documents against the filing structureApplicability, missing evidence and conflicting claims
LocalizationDraft Portuguese field and text translationsRegulatory meaning, technical terms, labels and declarations
AssemblyPopulate structured fields and cross-referencesCorrect device family, manufacturer/sites and route
ReleaseGenerate a review package and issue listSigned declarations, required certificates and final authorization

Maintain traceability from each submitted statement to its source document and revision. Flag missing or conflicting information rather than generating a plausible replacement. Manufacturer declarations, original evidence and required third-party certificates cannot be invented by an automated workflow.

Readiness checks before submission

Confirm the Brazil holder and its permissions, intended use, model grouping, local class, GMP evidence, labeling and applicable INMETRO/ANATEL requirements. Retain a controlled final package and a list of open issues. A notification route still requires compliant evidence even without a full premarket technical review.

The ANVISA registration instructions define the route, not the software used to assemble the file. Human approval should verify content, data accuracy and the actual legal requirements. Regulatory questions and changes after filing must be reflected in the controlled master.

Scope, cost and lifecycle support

Define whether the engagement includes extraction, translation, gap assessment, dossier completion, local-holder services, filing, authority responses and maintenance. Government fees, certification/testing costs and additional evidence work should be identified separately. Use Pure Global pricing to discuss the current scope rather than assuming an annual fee covers every possible compliance activity.

Connect the final file to Portuguese labeling, UDI/SIUD planning and postmarket controls. Faster preparation is useful only when the product and supporting evidence remain consistent and auditable.

How We Can Help

Faster submissions. Predictable costs. Local support.

Plan your device registration, local representation and ongoing compliance with Pure Global.

Pure Global regulatory support team

Frequently asked questions

Single Process,
Multiple Markets

When you partner with Pure Global, a single registration process opens doors to multiple countries. Our global subsidiaries make this streamlined path possible.

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Contact us